Agilon Free Cash Flow Yield vs Price To Sales Ratio Analysis

AGL Stock

USD 3.34 0.25 6.96%

Agilon Health financial indicator trend analysis is way more than just evaluating agilon health prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether agilon health is a good investment. Please check the relationship between Agilon Health Free Cash Flow Yield and its Price To Sales Ratio accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in agilon health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.

Free Cash Flow Yield vs Price To Sales Ratio

Free Cash Flow Yield vs Price To Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of agilon health Free Cash Flow Yield account and Price To Sales Ratio. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Agilon Health's Free Cash Flow Yield and Price To Sales Ratio is 0.9. Overlapping area represents the amount of variation of Free Cash Flow Yield that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of agilon health, assuming nothing else is changed. The correlation between historical values of Agilon Health's Free Cash Flow Yield and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Yield of agilon health are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Free Cash Flow Yield i.e., Agilon Health's Free Cash Flow Yield and Price To Sales Ratio go up and down completely randomly.

Correlation Coefficient

0.9

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Price To Sales Ratio

Price to Sales Ratio is figured by comparing agilon health stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Agilon Health sales, a figure that is much harder to manipulate than other agilon health multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Most indicators from Agilon Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into agilon health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in agilon health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.At this time, Agilon Health's Discontinued Operations is quite stable compared to the past year. Sales General And Administrative To Revenue is expected to rise to 0.14 this year, although the value of Tax Provision will most likely fall to about 936.1 K.

	2022	2023	2024	2025 (projected)
Interest Expense	4.5M	6.7M	6.0M	5.5M
Depreciation And Amortization	13.8M	20.2M	18.1M	16.8M

Interest Expense Depreciation And Amortization

Agilon Health fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Capital Lease Obligations	Inventory
Total Assets		-0.97	0.83	0.83	0.96	-0.96	0.97	0.6	-0.49	-0.95	0.66	0.47	0.98	0.97	0.28	-0.99	0.88	0.85	-0.74	1.0	0.77	-0.99	-0.97	1.0	0.83	-0.63
Short Long Term Debt Total	-0.97		-0.82	-0.82	-0.97	0.96	-0.99	-0.57	0.54	0.95	-0.64	-0.52	-0.93	-0.98	-0.34	0.97	-0.93	-0.84	0.64	-0.96	-0.74	0.98	0.98	-0.96	-0.72	0.56
Other Current Liab	0.83	-0.82		1.0	0.7	-0.91	0.87	0.93	-0.04	-0.93	0.96	0.02	0.89	0.73	-0.18	-0.9	0.58	1.0	-0.93	0.83	0.89	-0.87	-0.88	0.79	0.83	-0.92
Total Current Liabilities	0.83	-0.82	1.0		0.69	-0.91	0.86	0.93	-0.02	-0.93	0.96	0.0	0.89	0.73	-0.19	-0.9	0.57	1.0	-0.92	0.83	0.9	-0.87	-0.88	0.78	0.81	-0.9
Total Stockholder Equity	0.96	-0.97	0.7	0.69		-0.91	0.96	0.41	-0.69	-0.89	0.48	0.67	0.89	0.99	0.51	-0.92	0.98	0.72	-0.53	0.95	0.63	-0.95	-0.95	0.97	0.69	-0.43
Other Liab	-0.96	0.96	-0.91	-0.91	-0.91		-0.98	-0.73	0.35	0.98	-0.76	-0.32	-0.96	-0.92	-0.12	0.98	-0.83	-0.92	0.76	-0.95	-0.8	0.98	0.99	-0.94	-0.84	0.69
Net Tangible Assets	0.97	-0.99	0.87	0.86	0.96	-0.98		0.64	-0.51	-0.97	0.7	0.48	0.94	0.96	0.3	-0.98	0.9	0.88	-0.71	0.96	0.77	-0.98	-1.0	0.96	0.76	-0.65
Property Plant And Equipment Net	0.6	-0.57	0.93	0.93	0.41	-0.73	0.64		0.32	-0.75	0.98	-0.34	0.72	0.45	-0.51	-0.7	0.26	0.92	-0.92	0.61	0.85	-0.64	-0.66	0.54	0.77	-0.93
Net Debt	-0.49	0.54	-0.04	-0.02	-0.69	0.35	-0.51	0.32		0.33	0.21	-1.0	-0.32	-0.65	-0.97	0.38	-0.81	-0.05	-0.15	-0.47	-0.02	0.46	0.47	-0.54	-0.05	-0.2
Retained Earnings	-0.95	0.95	-0.93	-0.93	-0.89	0.98	-0.97	-0.75	0.33		-0.81	-0.3	-0.94	-0.9	-0.11	0.98	-0.8	-0.94	0.81	-0.94	-0.78	0.97	0.98	-0.93	-0.8	0.77
Accounts Payable	0.66	-0.64	0.96	0.96	0.48	-0.76	0.7	0.98	0.21	-0.81		-0.23	0.76	0.52	-0.4	-0.76	0.33	0.95	-0.95	0.67	0.86	-0.7	-0.72	0.6	0.75	-0.97
Cash	0.47	-0.52	0.02	0.0	0.67	-0.32	0.48	-0.34	-1.0	-0.3	-0.23		0.3	0.63	0.98	-0.36	0.79	0.03	0.17	0.45	0.01	-0.43	-0.45	0.52	0.03	0.22
Non Current Assets Total	0.98	-0.93	0.89	0.89	0.89	-0.96	0.94	0.72	-0.32	-0.94	0.76	0.3		0.91	0.1	-0.98	0.78	0.9	-0.83	0.99	0.85	-0.97	-0.95	0.97	0.91	-0.72
Non Currrent Assets Other	0.97	-0.98	0.73	0.73	0.99	-0.92	0.96	0.45	-0.65	-0.9	0.52	0.63	0.91		0.46	-0.94	0.97	0.75	-0.56	0.96	0.67	-0.97	-0.96	0.97	0.69	-0.46
Other Assets	0.28	-0.34	-0.18	-0.19	0.51	-0.12	0.3	-0.51	-0.97	-0.11	-0.4	0.98	0.1	0.46		-0.17	0.65	-0.17	0.34	0.27	-0.16	-0.25	-0.26	0.34	-0.16	0.37
Long Term Debt	-0.99	0.97	-0.9	-0.9	-0.92	0.98	-0.98	-0.7	0.38	0.98	-0.76	-0.36	-0.98	-0.94	-0.17		-0.83	-0.91	0.8	-0.98	-0.81	1.0	0.98	-0.97	-0.84	0.72
Cash And Short Term Investments	0.88	-0.93	0.58	0.57	0.98	-0.83	0.9	0.26	-0.81	-0.8	0.33	0.79	0.78	0.97	0.65	-0.83		0.6	-0.36	0.87	0.52	-0.88	-0.89	0.9	0.54	-0.28
Net Receivables	0.85	-0.84	1.0	1.0	0.72	-0.92	0.88	0.92	-0.05	-0.94	0.95	0.03	0.9	0.75	-0.17	-0.91	0.6		-0.92	0.85	0.89	-0.88	-0.89	0.8	0.82	-0.9
Good Will	-0.74	0.64	-0.93	-0.92	-0.53	0.76	-0.71	-0.92	-0.15	0.81	-0.95	0.17	-0.83	-0.56	0.34	0.8	-0.36	-0.92		-0.75	-0.85	0.74	0.73	-0.7	-0.85	0.96
Common Stock Total Equity	1.0	-0.96	0.83	0.83	0.95	-0.95	0.96	0.61	-0.47	-0.94	0.67	0.45	0.99	0.96	0.27	-0.98	0.87	0.85	-0.75		0.8	-0.99	-0.96	0.99	0.84	-0.63
Common Stock Shares Outstanding	0.77	-0.74	0.89	0.9	0.63	-0.8	0.77	0.85	-0.02	-0.78	0.86	0.01	0.85	0.67	-0.16	-0.81	0.52	0.89	-0.85	0.8		-0.78	-0.77	0.73	0.82	-0.77
Long Term Debt Total	-0.99	0.98	-0.87	-0.87	-0.95	0.98	-0.98	-0.64	0.46	0.97	-0.7	-0.43	-0.97	-0.97	-0.25	1.0	-0.88	-0.88	0.74	-0.99	-0.78		0.99	-0.98	-0.81	0.65
Non Current Liabilities Total	-0.97	0.98	-0.88	-0.88	-0.95	0.99	-1.0	-0.66	0.47	0.98	-0.72	-0.45	-0.95	-0.96	-0.26	0.98	-0.89	-0.89	0.73	-0.96	-0.77	0.99		-0.96	-0.79	0.67
Capital Surpluse	1.0	-0.96	0.79	0.78	0.97	-0.94	0.96	0.54	-0.54	-0.93	0.6	0.52	0.97	0.97	0.34	-0.97	0.9	0.8	-0.7	0.99	0.73	-0.98	-0.96		0.81	-0.58
Capital Lease Obligations	0.83	-0.72	0.83	0.81	0.69	-0.84	0.76	0.77	-0.05	-0.8	0.75	0.03	0.91	0.69	-0.16	-0.84	0.54	0.82	-0.85	0.84	0.82	-0.81	-0.79	0.81		-0.72
Inventory	-0.63	0.56	-0.92	-0.9	-0.43	0.69	-0.65	-0.93	-0.2	0.77	-0.97	0.22	-0.72	-0.46	0.37	0.72	-0.28	-0.9	0.96	-0.63	-0.77	0.65	0.67	-0.58	-0.72

Click cells to compare fundamentals

Agilon Health Account Relationship Matchups

Agilon Health fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	446.4M	1.6B	1.7B	1.7B	2.0B	1.3B
Short Long Term Debt Total	73.2M	48.4M	43.5M	52.3M	47.1M	47.3M
Other Current Liab	7.1M	242.3M	356.1M	968.1M	1.1B	1.2B
Total Current Liabilities	266.8M	357.0M	535.1M	977.2M	1.1B	1.2B
Total Stockholder Equity	(284.7M)	1.1B	1.0B	661.8M	761.1M	501.2M
Property Plant And Equipment Net	16.0M	9.2M	20.1M	41.0M	47.1M	49.5M
Net Debt	(33.6M)	(991.6M)	(453.6M)	(55.3M)	(49.7M)	(52.2M)
Retained Earnings	(551.2M)	(957.7M)	(1.1B)	(1.3B)	(1.2B)	(1.3B)
Accounts Payable	256.7M	109.6M	174.0M	968.1M	1.1B	1.2B
Cash	106.8M	1.0B	497.1M	107.6M	123.7M	117.5M
Non Current Assets Total	152.2M	219.1M	246.2M	260.8M	299.9M	227.8M
Non Currrent Assets Other	34.1M	113.0M	116.9M	87.1M	100.2M	82.9M
Other Assets	34.1M	225.9M	86.5M	1.0	1.15	1.09
Long Term Debt	64.7M	43.4M	38.5M	32.3M	29.1M	39.4M
Cash And Short Term Investments	106.8M	1.0B	909.0M	488.3M	561.6M	586.9M
Net Receivables	144.6M	293.4M	492.4M	942.5M	1.1B	1.1B
Liabilities And Stockholders Equity	446.4M	1.6B	1.7B	1.7B	2.0B	1.3B
Non Current Liabilities Total	464.3M	137.7M	121.8M	102.7M	92.4M	87.8M
Capital Lease Obligations	5.5M	7.9M	9.9M	10.9M	12.5M	9.2M
Other Current Assets	42.8M	33.7M	81.7M	49.3M	56.7M	48.6M
Other Stockholder Equity	264.0M	2.0B	2.1B	2.0B	2.3B	1.5B
Total Liab	731.1M	494.7M	656.9M	1.1B	1.2B	791.4M
Net Invested Capital	(217.0M)	1.1B	1.1B	700.4M	805.5M	560.2M
Property Plant And Equipment Gross	16.0M	29.1M	42.5M	55.3M	63.6M	35.6M
Total Current Assets	294.2M	1.4B	1.5B	1.5B	1.7B	1.1B
Accumulated Other Comprehensive Income	(7.3M)	0.0	(5.6M)	(2.3M)	(2.6M)	(2.8M)
Capital Stock	2.5M	4.0M	4.1M	4.1M	4.7M	3.8M
Non Current Liabilities Other	74.6M	94.3M	83.3M	59.5M	53.5M	60.5M
Net Working Capital	27.4M	1.0B	916.2M	502.9M	578.4M	550.6M
Intangible Assets	60.5M	55.4M	67.7M	63.8M	57.4M	51.0M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether agilon health is a strong investment it is important to analyze Agilon Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Agilon Health's future performance. For an informed investment choice regarding Agilon Stock, refer to the following important reports:

How To Invest In Agilon

Details

Is Agilon Stock a good investment?

Details

What is Agilon Health's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in agilon health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.

You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilon Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

11.951

Earnings Share

(0.76)

Revenue Per Share

13.717

Quarterly Revenue Growth

0.276

Return On Assets

(0.1)

The market value of agilon health is measured differently than its book value, which is the value of Agilon that is recorded on the company's balance sheet. Investors also form their own opinion of Agilon Health's value that differs from its market value or its book value, called intrinsic value, which is Agilon Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilon Health's market value can be influenced by many factors that don't directly affect Agilon Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Agilon Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilon Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilon Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Agilon Free Cash Flow Yield vs Price To Sales Ratio Analysis

Free Cash Flow Yield vs Price To Sales Ratio

Free Cash Flow Yield vs Price To Sales Ratio Correlation Analysis

Correlation Coefficient

Free Cash Flow Yield

Price To Sales Ratio

Agilon Health fundamental ratios Correlations

Agilon Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Agilon Health fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock Total Equity	+ 1.0	Total Assets
Capital Surpluse	+ 1.0	Total Assets
Total Current Liabilities	+ 1.0	Other Current Liab
Net Receivables	+ 1.0	Other Current Liab
Net Receivables	+ 1.0	Total Current Liabilities
Long Term Debt Total	+ 1.0	Long Term Debt

Cash	- 1.0	Net Debt
Non Current Liabilities Total	- 1.0	Net Tangible Assets
Long Term Debt Total	- 0.99	Common Stock Total Equity
Net Tangible Assets	- 0.99	Short Long Term Debt Total
Long Term Debt Total	- 0.99	Total Assets
Long Term Debt	- 0.99	Total Assets